Ms. Tillett is the Chief Scientific Officer for Kenvue. In this role, she oversees a multi-faceted Research & Development organization dedicated to consumer health science and innovation. She leads the company’s efforts to deliver science-backed products and solutions that fuel growth and improve the personal health and wellness of people globally.

Tillett is charged with setting the strategy for the company’s innovation pipeline across its Skin Health & Beauty, Self Care, and Essential Health segments,leading a global R&D team including New Product & Packaging Development, Sustainability, Medical Safety and Regulatory Affairs. She is a broad-based, global scientific leader with over 20 years of healthcare experience and a passion to deliver innovations that bring together research and consumer empathy.

She is recognized for developing strong leaders in the organization and is an executive sponsor for Learning & Development and for Kenvue’s Diversity, Equity & Inclusion mission. She also has a track record for supporting STEM in the community, serving as the co- executive sponsor for Kenvue’s approach to Equity in STEM.

Prior to Kenvue, Tillett served as Global Head, R&D, for Johnson & Johnson Consumer Health. Under her leadership, the R&D team put Self Care in the hands of consumers by leaning into digital applications,focused on more inclusive innovation in Skin Health, and leaned into its Healthy Lives Mission in Essential Health by making some of the company’s most iconic products more sustainable.

Before joining Johnson & Johnson Consumer Health, Tillett served as interim Global Head of Consumer R&D at GSK. She was the R&D leader for the GSK/Novartis joint venture, and she also served on the leadership team creating the new GSK/Pfizer Consumer Healthcare joint venture.

Tillett holds a BSc in applied chemistry and a PhD in medicinal chemistry from Kingston University, UK.